{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:24:17Z","timestamp":1795083857063,"version":"4.10.2"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":6403,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1111\/j.1538-7836.2005.01442.x","type":"journal-article","created":{"date-parts":[[2005,6,9]],"date-time":"2005-06-09T13:37:46Z","timestamp":1118324266000},"page":"1213-1217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke"],"prefix":"10.1016","volume":"3","author":[{"given":"A.J.C.","family":"SLOOTER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.R.","family":"ROSENDAAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.C.","family":"TANIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"KEMMEREN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"VAN DER GRAAF","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"ALGRA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0015","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3\u2032\u2010untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0020","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral\u2010contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0025","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.ATV.19.3.700","article-title":"Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis","volume":"19","author":"Martinelli","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0030","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0002-8703(03)00519-2","article-title":"Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta\u2010analysis of published studies","volume":"146","author":"Kim","year":"2003","journal-title":"Am Heart J"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0035","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/01.CIR.0000051465.94572.D0","article-title":"No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age","volume":"107","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0040","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-2141.2003.04454.x","article-title":"Prothrombotic coagulation defects and cardiovascular risk factors in young women with acute myocardial infarction","volume":"122","author":"Tanis","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0045","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1182\/blood-2004-03-0897","article-title":"Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case\u2010control studies from the Copenhagen City Heart Study","volume":"104","author":"Frederiksen","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0050","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.STR.0000015345.61324.3F","article-title":"Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischaemic stroke","volume":"33","author":"Kemmeren","year":"2002","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0055","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.284.1.72","article-title":"Ischaemic stroke risk with oral contraceptives: a meta\u2010analysis","volume":"284","author":"Gillum","year":"2000","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0060","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1160\/TH03-11-0690","article-title":"Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischaemic stroke","volume":"91","author":"Aznar","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0065","first-page":"536","article-title":"Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease","volume":"48","author":"Kang","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nat Genet"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0075","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischaemic heart disease and stroke: a meta\u2010analysis","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0080","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta\u2010analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0085","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/brain\/awh023","article-title":"Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction","volume":"127","author":"Hassan","year":"2004","journal-title":"Brain"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0090","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1055\/s-0038-1653788","article-title":"Sensitivity to activated protein C; influence of oral contraceptives and sex","volume":"73","author":"Henkens","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0095","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood-2003-04-1285","article-title":"Effect of second\u2010 and third\u2010generation oral contraceptives on the protein C system in the absence or presence of the factor V Leiden mutation: a randomized trial","volume":"103","author":"Kemmeren","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0100","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa003216","article-title":"Oral contraceptives and the risk of myocardial infarction","volume":"345","author":"Tanis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1538-7836.2003.00079.x","article-title":"The RATIO Study: oral contraceptives and the risk of peripheral arterial disease in young women","volume":"1","author":"Van Den Bosch","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0110","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1161\/01.STR.0000081224.15480.52","article-title":"Are changes in mortality from stroke caused by changes in stroke event rates or case fatality? Results from the WHO MONICA Project","volume":"34","author":"Sarti","year":"2003","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0115","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.STR.19.8.977","article-title":"Incidence of stroke in young adults in Florence, Italy","volume":"19","author":"Nencini","year":"1988","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0120","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/01.CIR.97.11.1037","article-title":"Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A","volume":"97","author":"Doggen","year":"1998","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0125","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood.V89.8.2817","article-title":"Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women","volume":"89","author":"Rosendaal","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01442.x_bb0130","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood.V90.5.1747","article-title":"A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women","volume":"90","author":"Rosendaal","year":"1997","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2005.01442.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622160642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622160642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2005.01442.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:35:06Z","timestamp":1761532506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622160642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S1538783622160642"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01442.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01442.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}